WebFeb 13, 2024 · BOSTON-- ( BUSINESS WIRE )-- Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the supplemental New Drug Application (sNDA) for LINZESS ® (linaclotide) for the treatment of children and adolescents ages 6 … WebIronwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI … Mr. Emany has served as our chief financial officer since December 2024. Prior to … The Boston Globe named Ironwood Pharmaceuticals a Top Place to Work for … Our in-market product, LINZESS® (linaclotide), discovered in-house, is the … Ironwood Pharmaceuticals wants to make our careers website accessible to all … In November 2024 into a collaboration and license option agreement with COUR … Ironwood Pharmaceuticals. 100 Summer Street Suite 2300 Boston MA 02110. … Ironwood Pharmaceuticals is a patient-focused, biopharmaceutical company on … By providing your email address below, you are providing consent to Ironwood … One in five Americans suffer from GI diseases, resulting in millions of hospital …
Ironwood Pharmaceuticals, Inc. - Ironwood Pharmaceuticals to …
WebJul 22, 2024 · BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its second quarter 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, August 5, 2024. Individuals interested in participating in the call should dial (833) 350-1432 (U.S. and Canada) or (647) 689-6932 … WebJun 13, 2024 · CAMBRIDGE, Mass.-- (BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, today announced that the company plans to relocate its headquarters to a new office in downtown Boston from its current location in Cambridge, Massachusetts. optionz beauty high wycombe
Allspring Global Investments Holdings LLC Reduces Position in Ironwood …
WebApr 11, 2024 · By Colin Kellaher Ironwood Pharmaceuticals Inc. on Tuesday said it has eliminated the role of chief operating officer in a streamlining of the healthcare company's … WebMar 6, 2024 · Ironwood Pharmaceuticals is part of the Manufacturing industry, and located in Massachusetts, United States. Ironwood Pharmaceuticals Location 100 Summer St Ste 2300, Boston, Massachusetts, 02110, United States Description Industry Pharmaceuticals Healthcare Discover more about Ironwood Pharmaceuticals Org Chart - Ironwood … WebAug 26, 2024 · BOSTON-- (BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, today announced that the U.S. Food and Drug Administration (FDA) approved a revised label for LINZESS ® (linaclotide) based on clinical safety data that has been generated thus far in pediatric studies. porto borges